Skip to main content
Erschienen in: Annals of Hematology 10/2009

01.10.2009 | Original Article

Mutations in HAMP and HJV genes and their impact on expression of clinical hemochromatosis in a cohort of 100 Spanish patients homozygous for the C282Y mutation of HFE gene

verfasst von: Albert Altès, Vanessa Bach, Angels Ruiz, Anna Esteve, Jordi Felez, Angel F. Remacha, M. Pilar Sardà, Montserrat Baiget

Erschienen in: Annals of Hematology | Ausgabe 10/2009

Einloggen, um Zugang zu erhalten

Abstract

Most hereditary hemochromatosis (HH) patients are homozygous for the C282Y mutation of the HFE gene. Nevertheless, penetrance of the disease is very variable. In some patients, penetrance can be mediated by concomitant mutations in other iron master genes. We evaluated the clinical impact of hepcidin (HAMP) and hemojuvelin mutations in a cohort of 100 Spanish patients homozygous for the C282Y mutation of the HFE gene. HAMP and hemojuvelin mutations were evaluated in all patients by bidirectional direct cycle sequencing. Phenotype–genotype interactions were evaluated. A heterozygous mutation of the HAMP gene (G71D) was found in only one out of 100 cases. Following, we performed a study of several members of that family, and we observed several members had a digenic inheritance of the C282Y mutation of the HFE gene and the G71D mutation of the HAMP gene. This mutation in the HAMP gene did not modify the phenotype of the individuals who were homozygous for the C282Y mutation. One other patient presented a new polymorphism in the hemojuvelin gene, without consequences in iron load or clinical course of the disease. In conclusion, HAMP and hemojuvelin mutations are rare among Spanish HH patients, and their impact in this population is not significant.
Literatur
1.
Zurück zum Zitat Adams PC, Reboussin DM, Barton JC, McLaren CE, Eckfeldt JH, McLaren GD, Dawkins FW, Acton RT, Harris EL, Gordeuk VR, Leiendecker-Foster C, Speechley M, Snively BM, Holup JL, Thomson E, Sholinsky P, Hemochromatosis and Iron Overload Screening (HEIRS) Study Research Investigators (2005) Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med 352:1769–1778 doi:10.1056/NEJMoa041534 PubMedCrossRef Adams PC, Reboussin DM, Barton JC, McLaren CE, Eckfeldt JH, McLaren GD, Dawkins FW, Acton RT, Harris EL, Gordeuk VR, Leiendecker-Foster C, Speechley M, Snively BM, Holup JL, Thomson E, Sholinsky P, Hemochromatosis and Iron Overload Screening (HEIRS) Study Research Investigators (2005) Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med 352:1769–1778 doi:10.​1056/​NEJMoa041534 PubMedCrossRef
2.
Zurück zum Zitat Altes A, Ruiz A, Barceló MJ, Remacha AF, Puig T, Maya AJ, Castell C, Amate JM, Saz Z, Baiget M (2004) Prevalence of C282Y, H63D and S65C mutations of HFE gene in 1146 newborns from a region of Northern Spain. Genet Test 8:407–410 doi:10.1089/gte.2004.8.407 PubMedCrossRef Altes A, Ruiz A, Barceló MJ, Remacha AF, Puig T, Maya AJ, Castell C, Amate JM, Saz Z, Baiget M (2004) Prevalence of C282Y, H63D and S65C mutations of HFE gene in 1146 newborns from a region of Northern Spain. Genet Test 8:407–410 doi:10.​1089/​gte.​2004.​8.​407 PubMedCrossRef
3.
Zurück zum Zitat Altes A, Ruiz A, Martinez C, Esteve A, Vela MD, Remacha AF, Sarda P, Bach V, Baiget M (2007) The relationship between iron overload and clinical characteristics in a Spanish cohort of 100 C282Y homozygous hemochromatosis patients. Ann Hematol 86:831–835 doi:10.1007/s00277-007-0336-0 PubMedCrossRef Altes A, Ruiz A, Martinez C, Esteve A, Vela MD, Remacha AF, Sarda P, Bach V, Baiget M (2007) The relationship between iron overload and clinical characteristics in a Spanish cohort of 100 C282Y homozygous hemochromatosis patients. Ann Hematol 86:831–835 doi:10.​1007/​s00277-007-0336-0 PubMedCrossRef
6.
Zurück zum Zitat Biasiotto G, Belloli S, Ruggeri G, Zanella I, Gerardi G, Corrado M, Gobbi E, Albertini A, Arosio P (2003) Identification of new mutations of the HFE hepcidin, and transferring receptor 2 genes by denaturing HPLC analysis of individuals with biochemical indications of iron overload. Clin Chem 49:1981–1988 doi:10.1373/clinchem.2003.023440 PubMedCrossRef Biasiotto G, Belloli S, Ruggeri G, Zanella I, Gerardi G, Corrado M, Gobbi E, Albertini A, Arosio P (2003) Identification of new mutations of the HFE hepcidin, and transferring receptor 2 genes by denaturing HPLC analysis of individuals with biochemical indications of iron overload. Clin Chem 49:1981–1988 doi:10.​1373/​clinchem.​2003.​023440 PubMedCrossRef
7.
Zurück zum Zitat Biasiotto G, Roetto A, Daraio F, Polotti A, Gerardi GM, Girelli D, Cremonesi L, Arosio P, Camaschella C (2004) Identification of new mutations of hepcidin and hemojuvelin in patients with HFE C282Y allele. Blood Cells Mol Dis 33:338–343 doi:10.1016/j.bcmd.2004.08.002 PubMedCrossRef Biasiotto G, Roetto A, Daraio F, Polotti A, Gerardi GM, Girelli D, Cremonesi L, Arosio P, Camaschella C (2004) Identification of new mutations of hepcidin and hemojuvelin in patients with HFE C282Y allele. Blood Cells Mol Dis 33:338–343 doi:10.​1016/​j.​bcmd.​2004.​08.​002 PubMedCrossRef
8.
Zurück zum Zitat Camaschella C, Roetto A, Cali A, De Gobbi M, Garozzo G, Carella M, Majorano N, Totaro A, Gasparini P (2000) The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet 25:14–15 doi:10.1038/75534 PubMedCrossRef Camaschella C, Roetto A, Cali A, De Gobbi M, Garozzo G, Carella M, Majorano N, Totaro A, Gasparini P (2000) The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet 25:14–15 doi:10.​1038/​75534 PubMedCrossRef
9.
Zurück zum Zitat Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo R Jr, Ellis MC, Fullan A, Hinton LM, Jones NL, Kimmel BE, Kronmal GS, Lauer P, Lee VK, Loeb DB, Mapa FA, McClelland E, Meyer NC, Mintier GA, Moeller N, Moore T, Morikang E, Prass CE, Quintana L, Starnes SM, Schatzman RC, Brunke KJ, Drayna DT, Risch NJ, Bacon BR, Wolff RK (1996) A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13:399–408 doi:10.1038/ng0896-399 PubMedCrossRef Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo R Jr, Ellis MC, Fullan A, Hinton LM, Jones NL, Kimmel BE, Kronmal GS, Lauer P, Lee VK, Loeb DB, Mapa FA, McClelland E, Meyer NC, Mintier GA, Moeller N, Moore T, Morikang E, Prass CE, Quintana L, Starnes SM, Schatzman RC, Brunke KJ, Drayna DT, Risch NJ, Bacon BR, Wolff RK (1996) A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13:399–408 doi:10.​1038/​ng0896-399 PubMedCrossRef
11.
Zurück zum Zitat Lanzara C, Roetto A, Daraio F, Rivard S, Ficarella R, Simard H, Cox TM, Cazzola M, Piperno A, Gimenez-Roqueplo AP, Grammatico P, Bolina S, Gasparini P, Camaschella C (2004) Spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis. Blood 103:4317–4321 doi:10.1182/blood-2004-01-0192 PubMedCrossRef Lanzara C, Roetto A, Daraio F, Rivard S, Ficarella R, Simard H, Cox TM, Cazzola M, Piperno A, Gimenez-Roqueplo AP, Grammatico P, Bolina S, Gasparini P, Camaschella C (2004) Spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis. Blood 103:4317–4321 doi:10.​1182/​blood-2004-01-0192 PubMedCrossRef
12.
Zurück zum Zitat Le Gac G, Scotet V, Ka C, Gourlaouen I, Bryckaert L, Jacolot S, Mura C, Férec C (2004) The recently identified type 2A juvenile haemochromatosis gene (HJV), a second candidate modifier of the C282Y homozygous phenotype. Hum Mol Genet 13:1913–1918 doi:10.1093/hmg/ddh206 PubMedCrossRef Le Gac G, Scotet V, Ka C, Gourlaouen I, Bryckaert L, Jacolot S, Mura C, Férec C (2004) The recently identified type 2A juvenile haemochromatosis gene (HJV), a second candidate modifier of the C282Y homozygous phenotype. Hum Mol Genet 13:1913–1918 doi:10.​1093/​hmg/​ddh206 PubMedCrossRef
14.
Zurück zum Zitat Majore S, Binni F, Ricerca BM, Brioli G, Grammatico P (2002) Absence of hepcidin gene mutations in 10 Italian patients with primary iron overload. Haematologica 87:221–222PubMed Majore S, Binni F, Ricerca BM, Brioli G, Grammatico P (2002) Absence of hepcidin gene mutations in 10 Italian patients with primary iron overload. Haematologica 87:221–222PubMed
15.
Zurück zum Zitat Merryweather-Clarke AT, Cadet E, Bomford A, Capron D, Viprakasit V, Miller A, McHugh PJ, Chapman RW, Pointon JJ, Wimhurst VL, Livesey KJ, Tanphaichitr V, Rochette J, Robson KJ (2003) Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis. Hum Mol Genet 12:2241–2247 doi:10.1093/hmg/ddg225 PubMedCrossRef Merryweather-Clarke AT, Cadet E, Bomford A, Capron D, Viprakasit V, Miller A, McHugh PJ, Chapman RW, Pointon JJ, Wimhurst VL, Livesey KJ, Tanphaichitr V, Rochette J, Robson KJ (2003) Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis. Hum Mol Genet 12:2241–2247 doi:10.​1093/​hmg/​ddg225 PubMedCrossRef
16.
Zurück zum Zitat Montosi G, Donovan A, Totaro A, Garuti C, Pignatti E, Cassanelli S, Trenor CC, Gasparini P, Andrews NC, Pietrangelo A (2001) Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest 108:619–623PubMed Montosi G, Donovan A, Totaro A, Garuti C, Pignatti E, Cassanelli S, Trenor CC, Gasparini P, Andrews NC, Pietrangelo A (2001) Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest 108:619–623PubMed
17.
Zurück zum Zitat Njajou OT, Vaessen N, Joosse M, Berghuis B, van Dongen JW, Breuning MH, Snijders PJ, Rutten WP, Sandkuijl LA, Oostra BA, vanDuijn CM, Heutink P (2001) A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat Genet 28:213–214 doi:10.1038/90038 PubMedCrossRef Njajou OT, Vaessen N, Joosse M, Berghuis B, van Dongen JW, Breuning MH, Snijders PJ, Rutten WP, Sandkuijl LA, Oostra BA, vanDuijn CM, Heutink P (2001) A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat Genet 28:213–214 doi:10.​1038/​90038 PubMedCrossRef
18.
Zurück zum Zitat Papanikolaou G, Sauels ME, Ludwig EH, MacDonald MLE, Franchini PL, Dubé MP, Andres L, MacFarlane J, Sakellaropoulos N, Politou M, Nemeth E, Thompson J, Risler JK, Zaborowska C, Babakaiff R, Radomski CC, Pape TD, Davidas O, Christakis J, Brissot P, Lockitch G, Ganz T, Hayden MR, Goldberg YP (2004) Mutation in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet 36:77–82 doi:10.1038/ng1274 PubMedCrossRef Papanikolaou G, Sauels ME, Ludwig EH, MacDonald MLE, Franchini PL, Dubé MP, Andres L, MacFarlane J, Sakellaropoulos N, Politou M, Nemeth E, Thompson J, Risler JK, Zaborowska C, Babakaiff R, Radomski CC, Pape TD, Davidas O, Christakis J, Brissot P, Lockitch G, Ganz T, Hayden MR, Goldberg YP (2004) Mutation in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet 36:77–82 doi:10.​1038/​ng1274 PubMedCrossRef
21.
Zurück zum Zitat Roetto A, Papanikolau G, Politou M, Alberti F, Girelli D, Christakis J, Loukopoulos D, Camaschella C (2003) Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet 33:21–22 doi:10.1038/ng1053 PubMedCrossRef Roetto A, Papanikolau G, Politou M, Alberti F, Girelli D, Christakis J, Loukopoulos D, Camaschella C (2003) Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet 33:21–22 doi:10.​1038/​ng1053 PubMedCrossRef
22.
Zurück zum Zitat Roetto A, Daraio F, Porporato P, Caruso R, Cox TM, Cazzola M, Gasparini P, Piperno A, Camaschella C (2004) Screening hepcidin for mutations in juvenile hemochromatosis: identification of a new mutation (C70R). Blood 103:2407–2409 doi:10.1182/blood-2003-10-3390 PubMedCrossRef Roetto A, Daraio F, Porporato P, Caruso R, Cox TM, Cazzola M, Gasparini P, Piperno A, Camaschella C (2004) Screening hepcidin for mutations in juvenile hemochromatosis: identification of a new mutation (C70R). Blood 103:2407–2409 doi:10.​1182/​blood-2003-10-3390 PubMedCrossRef
Metadaten
Titel
Mutations in HAMP and HJV genes and their impact on expression of clinical hemochromatosis in a cohort of 100 Spanish patients homozygous for the C282Y mutation of HFE gene
verfasst von
Albert Altès
Vanessa Bach
Angels Ruiz
Anna Esteve
Jordi Felez
Angel F. Remacha
M. Pilar Sardà
Montserrat Baiget
Publikationsdatum
01.10.2009
Verlag
Springer-Verlag
Erschienen in
Annals of Hematology / Ausgabe 10/2009
Print ISSN: 0939-5555
Elektronische ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-009-0705-y

Weitere Artikel der Ausgabe 10/2009

Annals of Hematology 10/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.